• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.

Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem. 2005 Mar 04; 280(9):8022-30.

View in: PubMed

subject areas
  • 14-3-3 Proteins
  • Adenoviridae
  • Animals
  • Apoptosis
  • bcl-Associated Death Protein
  • Blotting, Western
  • Bradykinin
  • Carrier Proteins
  • Caspase 3
  • Caspases
  • Cell Survival
  • DNA
  • DNA Fragmentation
  • DNA, Complementary
  • Gene Transfer Techniques
  • Genes, Dominant
  • Glycogen Synthase Kinase 3
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Hypoxia
  • Immunohistochemistry
  • Immunoprecipitation
  • In Situ Nick-End Labeling
  • Ischemia
  • Kallikreins
  • Kinins
  • Lithium
  • Male
  • Myocardium
  • Myocytes, Cardiac
  • Oxygen
  • Phosphorylation
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Rats, Wistar
  • Recombinant Proteins
  • Reperfusion Injury
  • Signal Transduction

authors with profiles
  • Lee Chao
  • Julie Chao